Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B | Zendy

Ertuğrul Güçlü | Zendy; Nazan Tuna | Zendy; Oğuz Karabay | Zendy; Sıla Akhan | Zendy; Hürrem Bodur | Zendy; Bahadır Ceylan | Zendy; Tuna Demırdal | Zendy; Kutbettin Demırdağ | Zendy; Neşe Demirtürk | Zendy; Hasan Çetin Ekerbiçer | Zendy; Serpil Erol | Zendy; Şaban Esen | Zendy; Ömer Evirgen | Zendy; Mehmet Faruk Geyik | Zendy; Alper Gündüz | Zendy; Mustafa Kasım Karahocagil | Zendy; Ömer Faruk Kökoğlu | Zendy; Davut Özdemir | Zendy; Nail Özgüneş | Zendy; Fatma Sargın | Zendy; Selma Tosun | Zendy; Emin Ediz Tütüncü | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B

Author(s) -

Ertuğrul Güçlü,

Nazan Tuna,

Oğuz Karabay,

Sıla Akhan,

Hürrem Bodur,

Bahadır Ceylan,

Tuna Demırdal,

Kutbettin Demırdağ,

Neşe Demirtürk,

Hasan Çetin Ekerbiçer,

Serpil Erol,

Şaban Esen,

Ömer Evirgen,

Mehmet Faruk Geyik,

Alper Gündüz,

Mustafa Kasım Karahocagil,

Ömer Faruk Kökoğlu,

Davut Özdemir,

Nail Özgüneş,

Fatma Sargın,

Selma Tosun,

Emin Ediz Tütüncü

Publication year - 2014

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.4953

Subject(s) - pegylated interferon , medicine , chronic hepatitis , gastroenterology , virology , immunology , hbeag , interferon , ribavirin , hepatitis b virus , virus , hbsag

Although pegylated interferons (pegIFNs) alpha-2a and alpha-2b have been used in chronic hepatitis B (CHB) treatment for many years, there are few studies concerning predictors of sustained virologic response (SVR) to pegIFN therapy. In this study, we aimed to investigate the predictors of response to pegIFN treatment in cases with HBeAg-negative CHB infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research